Cita APA

Peereboom, D. M., Alban, T. J., Grabowski, M. M., Alvarado, A. G., Otvos, B., Bayik, D., . . . Lathia, J. D. (2019). Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. JCI Insight.

Chicago Style Citation

Peereboom, David M., et al. "Metronomic Capecitabine As an Immune Modulator in Glioblastoma Patients Reduces Myeloid-derived Suppressor Cells." JCI Insight 2019.

Cita MLA

Peereboom, David M., et al. "Metronomic Capecitabine As an Immune Modulator in Glioblastoma Patients Reduces Myeloid-derived Suppressor Cells." JCI Insight 2019.